Legend Biotech CorporationLEGNNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-50.3%
5Y CAGR-33.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-50.3%/yr
vs -21.4%/yr prior
5Y CAGR
-33.9%/yr
Recent deceleration
Acceleration
-28.9pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 4.84 | -68.2% |
| 2023 | 15.25 | -48.6% |
| 2022 | 29.64 | -24.9% |
| 2021 | 39.47 | +144.4% |
| 2020 | 16.15 | -57.8% |
| 2019 | 38.26 | +14.3% |
| 2018 | 33.46 | -67.6% |
| 2017 | 103.43 | - |